Vincristine Sulfate, Topotecan Hydrochloride, and Cyclophosphamide With or Without Bevacizumab in Treating Young Patients With Refractory or First Recurrent Extracranial Ewing Sarcoma

Clinical Trial ID NCT00516295

PubWeight™ 3.16‹?›

🔗 Visit the ClinicalTrials.gov page for NCT00516295

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Sequencing Overview of Ewing Sarcoma: A Journey across Genomic, Epigenomic and Transcriptomic Landscapes. Int J Mol Sci 2015 0.82
2 Bone sarcomas: from biology to targeted therapies. Sarcoma 2012 0.82
3 Management of Ewing sarcoma family of tumors: Current scenario and unmet need. World J Orthop 2016 0.76
4 Advances in paediatric cancer treatment. Transl Pediatr 2014 0.76
Next 100